Literature DB >> 30175370

The adult patient with headache.

Vivien Min Er Lee1, Lai Lai Ang2, Derek Tuck Loong Soon3, Jonathan Jia Yuan Ong3, Victor Weng Keong Loh1.   

Abstract

Headaches are common in primary care. For safe assessment and management of the patient with headache, a focused history and physical examination are important to identify secondary headache, and find out whether an immediate referral to the emergency department or a non-emergent referral to the neurologist is warranted. The majority of patients with primary headache may be safely managed in the outpatient setting. Key steps include proper categorisation of the primary headache, attention to lifestyle and psychosocial factors, prescription of analgesics for acute pain relief, and the use of preventive medication when indicated. The patient with a cluster headache, a headache of uncertain diagnosis and/or poor response to preventive strategies or a migraine with persistent aura, or a headache with associated motor weakness, should be referred to a neurologist. Secondary headache and the diagnosis of medication overuse headache should be considered in a patient on long-term analgesics with unremitting headache. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  cluster headache; headache; migraine disorder; primary care; tension-type headache

Mesh:

Substances:

Year:  2018        PMID: 30175370      PMCID: PMC6109828          DOI: 10.11622/smedj.2018094

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  24 in total

Review 1.  Management of chronic headache.

Authors:  Roy G Beran
Journal:  Aust Fam Physician       Date:  2014-03

Review 2.  [Primary headache and depression].

Authors:  Gyöngyi Gesztelyi
Journal:  Orv Hetil       Date:  2004-11-28       Impact factor: 0.540

3.  Pearls: headache.

Authors:  David W Dodick
Journal:  Semin Neurol       Date:  2010-02-01       Impact factor: 3.420

4.  A community-based study of headache diagnosis and prevalence in Singapore.

Authors:  K-H Ho; B K-C Ong
Journal:  Cephalalgia       Date:  2003-02       Impact factor: 6.292

Review 5.  Behavioral medicine for migraine.

Authors:  Dawn C Buse; Frank Andrasik
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

6.  A self-administered screener for migraine in primary care: The ID Migraine validation study.

Authors:  R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

7.  Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.

Authors:  J V Khu; H C Siow; K H Ho
Journal:  Singapore Med J       Date:  2008-10       Impact factor: 1.858

8.  Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment.

Authors:  K Kroenke; R L Spitzer; J B Williams; M Linzer; S R Hahn; F V deGruy; D Brody
Journal:  Arch Fam Med       Date:  1994-09

9.  Migraine and reduced work performance: a population-based diary study.

Authors:  M Von Korff; W F Stewart; D J Simon; R B Lipton
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  Migraine--the forgotten epidemic: development of the EHF/WHA Rome Declaration on Migraine.

Authors:  Hans-Christoph Diener; Timothy J Steiner; Stewart J Tepper
Journal:  J Headache Pain       Date:  2006-12-10       Impact factor: 7.277

View more
  3 in total

1.  Managing tooth pain in general practice.

Authors:  Sky Wei Chee Koh; Chun Fai Li; John Ser Pheng Loh; Mun Loke Wong; Victor Weng Keong Loh
Journal:  Singapore Med J       Date:  2019-05       Impact factor: 1.858

2.  The curious case of an atypical headache, a case report and review of literature.

Authors:  Hamza Paracha; Syed Asim Hussain
Journal:  AME Case Rep       Date:  2020-10-30

3.  Images of the month 2: No laughing matter: Symptomatic Chiari malformation type I.

Authors:  Desmond B Teo
Journal:  Clin Med (Lond)       Date:  2022-07       Impact factor: 5.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.